BUZZ-U.S. STOCKS ON THE MOVE-Anavex, CSC, Cyclacel, Fitbit
Nov 30 (Reuters) - (For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks were little changed on Monday as investors awaited key economic data including the November jobs report this week and kept an eye on policy decisions by U.S. and European central banks. The Dow Jones industrial average was down 0.27 percent at 17,751.06, the S&P 500 was down 0.28 percent at 2,084.3 and the Nasdaq Composite was down 0.30 percent at 5,112.252.
** WAFERGEN BIO-SYSTEMS INC, $0.9278, +11.68 pct
** AETERNA ZENTARIS INC, $9.75, -11.84 pct
** CYCLACEL PHARMACEUTICALS INC, $0.76, -25.49 pct
Martin Shkreli, the controversial CEO of Turing Pharmaceuticals Inc, called the medical tool maker an "okay investment for sure," as he reviewed the company's financial reports on a livestream meeting with retail investors.
Shkreli also called cancer drug developers Aeterna Zentaris Inc and Cyclacel Pharmaceuticals Inc "pretty terrible" and "worthless".
** TRIBUNE PUBLISHING CO, $9.99, +7.54 pct Continued...